Structural organization and expression of the mouse gene encoding α-galactosidase A

Toshio Ohshima, Gary J. Murray, James W. Nagle, Jane M. Quirk, Matthias H. Kraus, Norman W. Barton, Roscoe O. Brady, Ashok B. Kulkarni

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

α-Galactosidase A (α-d-galactoside galactohydrolase, EC 3.2.1.22;αGalA) is a lysosomal enzyme that hydrolyses the α-d-galactosyl residues from glycosphingolipids. Fabry disease, an inherited X-linked recessive human metabolic disorder, results from a mutation in the αGalA gene at Xq22. As a prerequisite for generating a mouse model of Fabry disease by gene targeting, we have isolated and characterized the mouse αGalA gene and cDNA. A cloned mouse αGalA cDNA encoded a putative precursor protein of 419 amino acids (aa), including a 31-aa signal peptide (SP). The deduced aa sequence showed high homology (79%) with the human αtGalA protein. Nucleotide sequence analysis of genomic clones revealed that the overall structure and organization of the gene was very similar to that of human αGalA. All exon-intron splice junctions conformed to the GT/AG consensus sequence. Comparison of genomic and cDNA sequences revealed the ocurrence of two putative polyadenylation signals whose alternative use results in the two mouse αGalA transcripts of 1.4 and 3.6 kb. The 5′-flanking region of mouse αGalA had no typical TATA box. Several putative promoter-associated elements including Spl, AP1 and a potential cAMP-responsive element (CRE) were identified. Northern blot analysis revealed the widespread tissue distribution of mouse αGalA transcripts. Lower expression levels, however, were observed in some tissues, implying tissue-specific differences in αGalA promoter function.

Original languageEnglish
Pages (from-to)277-280
Number of pages4
JournalGene
Volume166
Issue number2
DOIs
Publication statusPublished - 1995 Dec 12
Externally publishedYes

Fingerprint

Galactosidases
Gene Expression
Fabry Disease
Complementary DNA
Genes
Amino Acids
Galactosides
Glycosphingolipids
TATA Box
Polyadenylation
Protein Precursors
Gene Targeting
5' Flanking Region
Consensus Sequence
Tissue Distribution
Protein Sorting Signals
Northern Blotting
Introns
Sequence Analysis
Amino Acid Sequence

Keywords

  • exon
  • Fabry disease
  • intron
  • lysosomal enzyme
  • promoter
  • Recombinant genomic DNA

ASJC Scopus subject areas

  • Genetics

Cite this

Ohshima, T., Murray, G. J., Nagle, J. W., Quirk, J. M., Kraus, M. H., Barton, N. W., ... Kulkarni, A. B. (1995). Structural organization and expression of the mouse gene encoding α-galactosidase A. Gene, 166(2), 277-280. https://doi.org/10.1016/0378-1119(95)00592-7

Structural organization and expression of the mouse gene encoding α-galactosidase A. / Ohshima, Toshio; Murray, Gary J.; Nagle, James W.; Quirk, Jane M.; Kraus, Matthias H.; Barton, Norman W.; Brady, Roscoe O.; Kulkarni, Ashok B.

In: Gene, Vol. 166, No. 2, 12.12.1995, p. 277-280.

Research output: Contribution to journalArticle

Ohshima, T, Murray, GJ, Nagle, JW, Quirk, JM, Kraus, MH, Barton, NW, Brady, RO & Kulkarni, AB 1995, 'Structural organization and expression of the mouse gene encoding α-galactosidase A', Gene, vol. 166, no. 2, pp. 277-280. https://doi.org/10.1016/0378-1119(95)00592-7
Ohshima, Toshio ; Murray, Gary J. ; Nagle, James W. ; Quirk, Jane M. ; Kraus, Matthias H. ; Barton, Norman W. ; Brady, Roscoe O. ; Kulkarni, Ashok B. / Structural organization and expression of the mouse gene encoding α-galactosidase A. In: Gene. 1995 ; Vol. 166, No. 2. pp. 277-280.
@article{97bf476a772f40669029c2b292581e3d,
title = "Structural organization and expression of the mouse gene encoding α-galactosidase A",
abstract = "α-Galactosidase A (α-d-galactoside galactohydrolase, EC 3.2.1.22;αGalA) is a lysosomal enzyme that hydrolyses the α-d-galactosyl residues from glycosphingolipids. Fabry disease, an inherited X-linked recessive human metabolic disorder, results from a mutation in the αGalA gene at Xq22. As a prerequisite for generating a mouse model of Fabry disease by gene targeting, we have isolated and characterized the mouse αGalA gene and cDNA. A cloned mouse αGalA cDNA encoded a putative precursor protein of 419 amino acids (aa), including a 31-aa signal peptide (SP). The deduced aa sequence showed high homology (79{\%}) with the human αtGalA protein. Nucleotide sequence analysis of genomic clones revealed that the overall structure and organization of the gene was very similar to that of human αGalA. All exon-intron splice junctions conformed to the GT/AG consensus sequence. Comparison of genomic and cDNA sequences revealed the ocurrence of two putative polyadenylation signals whose alternative use results in the two mouse αGalA transcripts of 1.4 and 3.6 kb. The 5′-flanking region of mouse αGalA had no typical TATA box. Several putative promoter-associated elements including Spl, AP1 and a potential cAMP-responsive element (CRE) were identified. Northern blot analysis revealed the widespread tissue distribution of mouse αGalA transcripts. Lower expression levels, however, were observed in some tissues, implying tissue-specific differences in αGalA promoter function.",
keywords = "exon, Fabry disease, intron, lysosomal enzyme, promoter, Recombinant genomic DNA",
author = "Toshio Ohshima and Murray, {Gary J.} and Nagle, {James W.} and Quirk, {Jane M.} and Kraus, {Matthias H.} and Barton, {Norman W.} and Brady, {Roscoe O.} and Kulkarni, {Ashok B.}",
year = "1995",
month = "12",
day = "12",
doi = "10.1016/0378-1119(95)00592-7",
language = "English",
volume = "166",
pages = "277--280",
journal = "Gene",
issn = "0378-1119",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Structural organization and expression of the mouse gene encoding α-galactosidase A

AU - Ohshima, Toshio

AU - Murray, Gary J.

AU - Nagle, James W.

AU - Quirk, Jane M.

AU - Kraus, Matthias H.

AU - Barton, Norman W.

AU - Brady, Roscoe O.

AU - Kulkarni, Ashok B.

PY - 1995/12/12

Y1 - 1995/12/12

N2 - α-Galactosidase A (α-d-galactoside galactohydrolase, EC 3.2.1.22;αGalA) is a lysosomal enzyme that hydrolyses the α-d-galactosyl residues from glycosphingolipids. Fabry disease, an inherited X-linked recessive human metabolic disorder, results from a mutation in the αGalA gene at Xq22. As a prerequisite for generating a mouse model of Fabry disease by gene targeting, we have isolated and characterized the mouse αGalA gene and cDNA. A cloned mouse αGalA cDNA encoded a putative precursor protein of 419 amino acids (aa), including a 31-aa signal peptide (SP). The deduced aa sequence showed high homology (79%) with the human αtGalA protein. Nucleotide sequence analysis of genomic clones revealed that the overall structure and organization of the gene was very similar to that of human αGalA. All exon-intron splice junctions conformed to the GT/AG consensus sequence. Comparison of genomic and cDNA sequences revealed the ocurrence of two putative polyadenylation signals whose alternative use results in the two mouse αGalA transcripts of 1.4 and 3.6 kb. The 5′-flanking region of mouse αGalA had no typical TATA box. Several putative promoter-associated elements including Spl, AP1 and a potential cAMP-responsive element (CRE) were identified. Northern blot analysis revealed the widespread tissue distribution of mouse αGalA transcripts. Lower expression levels, however, were observed in some tissues, implying tissue-specific differences in αGalA promoter function.

AB - α-Galactosidase A (α-d-galactoside galactohydrolase, EC 3.2.1.22;αGalA) is a lysosomal enzyme that hydrolyses the α-d-galactosyl residues from glycosphingolipids. Fabry disease, an inherited X-linked recessive human metabolic disorder, results from a mutation in the αGalA gene at Xq22. As a prerequisite for generating a mouse model of Fabry disease by gene targeting, we have isolated and characterized the mouse αGalA gene and cDNA. A cloned mouse αGalA cDNA encoded a putative precursor protein of 419 amino acids (aa), including a 31-aa signal peptide (SP). The deduced aa sequence showed high homology (79%) with the human αtGalA protein. Nucleotide sequence analysis of genomic clones revealed that the overall structure and organization of the gene was very similar to that of human αGalA. All exon-intron splice junctions conformed to the GT/AG consensus sequence. Comparison of genomic and cDNA sequences revealed the ocurrence of two putative polyadenylation signals whose alternative use results in the two mouse αGalA transcripts of 1.4 and 3.6 kb. The 5′-flanking region of mouse αGalA had no typical TATA box. Several putative promoter-associated elements including Spl, AP1 and a potential cAMP-responsive element (CRE) were identified. Northern blot analysis revealed the widespread tissue distribution of mouse αGalA transcripts. Lower expression levels, however, were observed in some tissues, implying tissue-specific differences in αGalA promoter function.

KW - exon

KW - Fabry disease

KW - intron

KW - lysosomal enzyme

KW - promoter

KW - Recombinant genomic DNA

UR - http://www.scopus.com/inward/record.url?scp=0029559014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029559014&partnerID=8YFLogxK

U2 - 10.1016/0378-1119(95)00592-7

DO - 10.1016/0378-1119(95)00592-7

M3 - Article

C2 - 8543175

AN - SCOPUS:0029559014

VL - 166

SP - 277

EP - 280

JO - Gene

JF - Gene

SN - 0378-1119

IS - 2

ER -